Cell-Free Translation for Single-Molecule Phenotype Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing protein samples for single molecule biophysics applications, such as smFRET, are inefficient and labor-intensive, particularly for cytotoxic or aggregation-prone proteins, due to the need for dual-labeling and purification, which often perturbs the protein structure and requires low-throughput processes.
Innovation Solution
The use of in vitro cell-free translation reactions to incorporate unnatural amino acids with reactive groups, allowing for site-specific labeling through click chemistry reactions, such as CuAAC, to produce dual-labeled proteins in a high-throughput manner, enabling the generation of modified polypeptide-ribosome or polypeptide-mRNA complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If in vivo production and dual-labeling methods are used, then sample labeling specificity is improved, but productivity deteriorates due to low-throughput process requiring minimum of two weeks
Solution Approach 1:
The patent replaces the mechanical/biological in vivo production system with an in vitro cell-free translation system. This substitution eliminates the need for living cells, plasmid cloning, and complex purification steps, thereby dramatically increasing productivity while maintaining labeling specificity through controlled in vitro conditions.
Solution Approach 2:
The patent segments the protein production and labeling process into distinct modular steps: (1) in vitro translation to produce protein with incorporated unnatural amino acids, (2) selective chemical labeling with fluorescent dyes, and (3) purification. This segmentation allows each step to be optimized independently and accelerates the overall process.
2Measurement precision
If traditional dual-labeling methods are used, then measurement precision for smFRET is improved, but loss of time increases due to multi-step purification and post-processing
Solution Approach 1:
The patent incorporates unnatural amino acids with reactive groups directly during the translation process itself, rather than performing labeling after protein production. This preliminary action of incorporating labeling-capable amino acids during synthesis eliminates subsequent time-consuming purification and labeling steps, reducing total preparation time while maintaining measurement precision.
3Manufacturing precision
If site-specific dye attachment methods are used, then manufacturing precision of labeling is improved, but device complexity increases due to requirement for unnatural amino acid tagging and purification
Solution Approach 1:
The patent introduces unnatural amino acids as intermediary molecules that serve as handles for site-specific labeling. These UAAs are incorporated during translation and provide reactive groups that enable controlled dye attachment. This intermediary approach simplifies the overall process by providing a standardized interface for labeling rather than requiring complex direct dye-protein conjugation methods.
4Adaptability or versatility
If in vivo expression is used, then adaptability for different protein samples is improved, but loss of substance increases due to need to purify away non-target proteins and truncated proteins
Solution Approach 1:
The patent uses in vitro cell-free translation systems that replicate the essential functions of in vivo protein synthesis without requiring living cells. This copying approach allows production of specific protein samples with controlled modifications while eliminating the need to purify away non-target and truncated proteins that arise in in vivo systems, thereby reducing protein loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach facilitates the production of high-quality dual-labeled protein samples with improved efficiency and specificity, reducing the time and variability associated with traditional methods, and allows for the screening of single molecule phenotypes and interactions.
Implementation Method 1
The reactive group on the incorporated unnatural amino acid is utilized for the attachment of a heterologous moiety to the unnatural amino acid, and thus the polypeptide, by a chemical reaction, e.g., by a click chemistry reaction
Implementation Method 2
copper(I)-catalyzed azide-alkyne cycloaddition, ligand-assisted copper catalyzed azide-alkyne cycloaddition (CuAAC)
Implementation Method 3
strain-promoted azide-alkyne cycloaddition (SPAAC)
Data Source
AI summary
Aspects of the present disclosure include methods of producing modified polypeptides and modified polypeptide-ribosome or polypeptide-mRNA complexes, and methods of screening polynucleotide and polypeptide libraries. The present disclosure also provides polypeptide libraries useful in screening for single molecule phenotypes. Also provided are kits useful for producing polypeptides capable of being modified using methods disclosed herein.